Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Businesses can grow rapidly by automating tasks, shaping efficient workflows, and creating an independent team that can thrive while maintaining profitability.